Johnson & Johnson
Johnson & Johnson consumer spin-off complete
Share exchange offer leaves J & J with just 9.5% of new consumer health outfit Kenvue Shares of newly-minted consumer health care operation Kenvue shares rose 1.4% in pre-market trading …
New consumer health company Kenvue explodes
Johnson & Johnson spin-off shares rocket 22% on stock exchange debut First GSK spun-off its consumer operation into Haleon, now Johnson & Johnson (J&J) has done the same with its consumer health …
J&J ordered to pay $846 million for role in opioid crisis
The pharmaceutical company says it will appeal the judgement A judge has fined drug manufacturer Johnson & Johnson and its pharmaceutical subsidiary Janssen US$572 million (AUD$846 million) after finding the …
Jury recommends $34m payout from J&J
Johnson & Johnson has been ordered to pay millions in damages to a woman who claimed her cancer was caused by using the company’s baby powder This week a California …
J&J wins reversal of $417m talc fine
A US judge has thrown out $US417m ($A533 million) award to a woman who claimed she developed ovarian cancer by using J&J talc-based baby powder The announcement follows the company’s …
Ovarian cancer patient wins $525 million from J&J
It is the largest payout so far in a string of lawsuits against Johnson & Johnson and its talc-based products A US jury has ordered Johnson & Johnson (J&J) to …
J&J ordered to pay $150m fine
Johnson & Johnson (J&J) has been hit with a $150M (US$110M) fine over the alleged safety of its baby powder Last week J&J was ordered by a US jury to …
Johnson & Johnson pulls claim its Band-Aids heal twice as fast
The company has withdrawn claims its Band-Aid products are “clinically proven” to heal wounds “two times faster” following a request to release clinical trial data Dr Ken Harvey from Monash …